Suppr超能文献

肌萎缩侧索硬化症患者的免疫特征及其对病毒和中枢神经系统抗原的细胞介导免疫反应。

Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens.

作者信息

Bartfeld H, Dham C, Donnenfeld H, Jashnani L, Carp R, Kascsak R, Vilcek J, Rapport M, Wallenstein S

出版信息

Clin Exp Immunol. 1982 Apr;48(1):137-46.

Abstract

The 'immunological profile' of amyotrophic lateral sclerosis (ALS) patients was established from standard tests for B- and T-cell function. This showed no significant difference from age and sex-matched other neurological (CNS) disease controls and normal subjects. Immune complex (IC) levels in ALS serum differed significantly from normal controls but not from CNS controls. There was no relation between the various indices of immune activity of IC levels and the clinical disability of the ALS patient or progression of the disease. Distribution of complement-fixing antibodies to poliovirus was similar to sera of ALS and control groups. The in vitro cell-mediated immune responses to poliovirus, however, were significantly greater in ALS patients than in CNS controls and were inversely related to the ALS disability score. Poliovirus has not been demonstrated in the CNS or extra-CNS tissues of ALS patients by conventional means but, if latent or defective poliovirus or related virus were present, this could account for sensitization and a possible autoimmune mechanism. ALS patients exhibited in vitro cellular immunity to ALS and normal CNS subfractions. These responses were not related to the ALS disability score or progression of the disease and probably represent epiphenomena.

摘要

肌萎缩侧索硬化症(ALS)患者的“免疫特征”是通过B细胞和T细胞功能的标准测试确定的。结果显示,与年龄和性别匹配的其他神经(中枢神经系统)疾病对照组及正常受试者相比,并无显著差异。ALS患者血清中的免疫复合物(IC)水平与正常对照组有显著差异,但与中枢神经系统疾病对照组无差异。IC水平的各种免疫活性指标与ALS患者的临床残疾程度或疾病进展之间没有关联。针对脊髓灰质炎病毒的补体结合抗体分布与ALS组和对照组的血清相似。然而,ALS患者对脊髓灰质炎病毒的体外细胞介导免疫反应明显强于中枢神经系统疾病对照组,且与ALS残疾评分呈负相关。通过传统方法在ALS患者的中枢神经系统或中枢神经系统外组织中未检测到脊髓灰质炎病毒,但如果存在潜伏或缺陷的脊髓灰质炎病毒或相关病毒,这可能解释了致敏现象及一种可能的自身免疫机制。ALS患者对ALS和正常中枢神经系统亚组分表现出体外细胞免疫。这些反应与ALS残疾评分或疾病进展无关,可能仅为附带现象。

相似文献

3
[The viral etiology of amyotrophic lateral sclerosis].
Mikrobiyol Bul. 1989 Apr;23(2):102-9.
4
Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients.
J Neuroimmunol. 1984 Feb;6(1):51-7. doi: 10.1016/0165-5728(84)90042-0.
5
Serum and CSF immunological findings in ALS.
Acta Neurol Scand. 1991 Feb;83(2):96-8. doi: 10.1111/j.1600-0404.1991.tb04656.x.
6
Cell-mediated immunity to polio and HLA antigens in amyotrophic lateral sclerosis.
Neurology. 1979 Jul;29(7):1040-4. doi: 10.1212/wnl.29.7.1040.
7
Polio antibodies and HLA antigens in amyotrophic lateral sclerosis.
Tissue Antigens. 1977 Oct;10(4):259-66. doi: 10.1111/j.1399-0039.1977.tb00755.x.
9
10
Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression.
J Neuroimmunol. 2009 Oct 30;215(1-2):96-101. doi: 10.1016/j.jneuroim.2009.07.011. Epub 2009 Aug 14.

引用本文的文献

1
Immunology of amyotrophic lateral sclerosis - role of the innate and adaptive immunity.
Front Neurosci. 2023 Nov 30;17:1277399. doi: 10.3389/fnins.2023.1277399. eCollection 2023.
2
Evaluation of Peripheral Immune Activation in Amyotrophic Lateral Sclerosis.
Front Neurol. 2021 Jun 24;12:628710. doi: 10.3389/fneur.2021.628710. eCollection 2021.
3
TDP-43-specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis.
Neurol Neuroimmunol Neuroinflamm. 2020 Dec 24;8(2). doi: 10.1212/NXI.0000000000000937. Print 2021 Mar.
4
Humoral factors in ALS patients during disease progression.
J Neuroinflammation. 2015 Jun 28;12:127. doi: 10.1186/s12974-015-0350-4.
5
Novel molecular biomarkers at the blood-brain barrier in ALS.
Biomed Res Int. 2014;2014:907545. doi: 10.1155/2014/907545. Epub 2014 May 11.
6
Melittin ameliorates the inflammation of organs in an amyotrophic lateral sclerosis animal model.
Exp Neurobiol. 2014 Mar;23(1):86-92. doi: 10.5607/en.2014.23.1.86. Epub 2014 Mar 27.
7
Humoral immune activation in amyotrophic lateral sclerosis patients.
Neurol Int. 2013 Feb 11;5(1):e3. doi: 10.4081/ni.2013.e3.
8
Motor neuron disease: etiology, pathogenesis and treatment--a review.
Ir J Med Sci. 1996 Jul-Sep;165(3):200-9. doi: 10.1007/BF02940251.
9
A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.
J Neurol Neurosurg Psychiatry. 1993 Apr;56(4):361-4. doi: 10.1136/jnnp.56.4.361.
10
Immunology of amyotrophic lateral sclerosis.
Springer Semin Immunopathol. 1985;8(1-2):141-52. doi: 10.1007/BF00197252.

本文引用的文献

1
FUNCTIONAL STUDIES OF CULTURED BRAIN TISSUES AS RELATED TO "DEMYELINATIVE DISORDERS".
Science. 1965 May 28;148(3674):1242-4. doi: 10.1126/science.148.3674.1242.
2
Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.
J Clin Microbiol. 1980 Jan;11(1):102-5. doi: 10.1128/jcm.11.1.102-105.1980.
3
ALS in Rochester, Minnesota, 1925-1977.
Neurology. 1980 May;30(5):463-70. doi: 10.1212/wnl.30.5.463.
4
Soluble antigen-antibody complexes and platelet aggregation.
Acta Pathol Microbiol Scand. 1969;77(2):309-17. doi: 10.1111/j.1699-0463.1969.tb04236.x.
5
The administration of guanidine in amyotrophic lateral sclerosis.
Neurology. 1974 Aug;24(8):721-8. doi: 10.1212/wnl.24.8.721.
7
Neutralizing antibodies to poliovirus and mumps virus in amyotrophic lateral sclerosis.
J Neurol Sci. 1974 Dec;23(4):537-40. doi: 10.1016/0022-510x(74)90025-2.
8
Preparation of synaptosomes and vesicles with sodium diatrizoate.
J Neurochem. 1974 Nov;23(5):943-9. doi: 10.1111/j.1471-4159.1974.tb10746.x.
9
A suppression of cellular immunity in patients with multiple sclerosis.
J Exp Med. 1973 Dec 1;138(6):1591-6. doi: 10.1084/jem.138.6.1591.
10
Cultures of tissues from patients with amyotrophic lateral sclerosis.
Arch Neurol. 1973 Nov;29(5):331-3. doi: 10.1001/archneur.1973.00490290071009.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验